MHH uses 101.4 million euros in funding for research in 2022
A symbol photo from the laboratory. Copyright: Karin Kaiser / MHH
03.04.2023
Hannover Medical School (MHH) has cracked the 100 million euro mark in third-party funding spent for the first time in its 58-year history. In 2022, researchers used a total of 101.4 million euros for their projects, which employ almost 1,400 people. In 2022, 585 new projects were started. This means that the MHH remains one of the most research-active university medical institutions in Germany. "This top performance shows that we are following the right path with our strategy of targeted focus and proximity between clinical and research priorities," emphasises MHH President Professor Dr Michael Manns.
Third-party funding is funding that the scientists obtain competitively with project applications to funding institutions such as the German Research Foundation, the European Union or foundations, associations and companies in an increasingly competitive environment with other universities and non-university research institutions in Germany and abroad. "Last year we were once again able to score points with our research focus 'Infection and Immunity' and received many research funds for SARSCoV2 and COVID19 research. 101.4 million euros is considerable for a divisional university like the MHH, the only independent medical university in Germany," says Professor Manns.